Shopping Cart
- Remove All
Your shopping cart is currently empty
Tanomastat is an orally bioavailable and non-peptidic biphenyl matrix metalloproteinases inhibitor. For MMP-2, MMP-3, MMP-9, MMP-13 the Ki values are 11, 143, 301, and 1470 nM respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 500 μg | $88 | 35 days | |
| 1 mg | $170 | 35 days | |
| 5 mg | $540 | 35 days | |
| 10 mg | $990 | 35 days |
| Description | Tanomastat is an orally bioavailable and non-peptidic biphenyl matrix metalloproteinases inhibitor. For MMP-2, MMP-3, MMP-9, MMP-13 the Ki values are 11, 143, 301, and 1470 nM respectively. |
| Targets&IC50 | MMP13:1470 nM (ki), MMP2:11 nM (ki), MMP9:301 nM (ki), MMP3:143 nM (ki) |
| In vitro | Tanomastat (1-00 μM; 5 days) inhibits tubule formation completely at 15-100 μM. Tanomastat (1-10000 nM; 6 hours) prevents matrix invasion by endothelial cells in a concentration-dependent manner (IC50=840 nM) [2][3]. |
| In vivo | Tanomastat (100 mg/kg; p.o.; daily for a 7-week period) inhibits local tumor regrowth and inhibits the number and volume of lung metastases [3]. |
| Synonyms | BAY 12-9566 |
| Molecular Weight | 410.91 |
| Formula | C23H19ClO3S |
| Cas No. | 179545-77-8 |
| Relative Density. | 1.33g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.